See Alex Lucio and 3B Medical, Inc. mentioned in the press!
“Lucio says 3B Medical ‘is actively looking for acquisitions and new product opportunities’ and plans to “add 12 new products and expand our product from the sleep space into oxygen and related respiratory areas.”
“We have looked at acquisitions and are near closing on our first, and we also have a fairly deep new product pipeline.”
“The difference between now and five years ago is the amount of people who even know what a CPAP is.”
This is just a small smattering of a handful of press mentions that 3B Medical Inc. Executive Vice President Alex Lucio has been quoted in. Below features press snippets from local publications such as the Florida Business Observer and The Tampa Bay Business Journal as well as placement in industry news such as HomeCare Magazine, Home Medical Equipment News, and MassDevice: The Medical Device Business Journal.
You can expect Alex Lucio and 3B Medical Inc., a manufacturer of healthcare devices for the sleep-disordered breathing market, to appear in many more local and trade publications as their company and portfolio expands in Central Florida. Their plans for 2018? Move production of their healthcare devices out of China to their headquarters in Winter Haven, Florida, which will add roughly 20 to 30 new manufacturing jobs in the area. They are also looking to secure a home medical equipment license to conduct direct-to-patient sales and expand their product portfolio internally as well as externally through acquisitions.
A medical supply firm's expansion into manufacturing could create 30 jobs in Winter Haven – or Missouri.
WINTER HAVEN, Fla. – You could call 2017 a rebuilding year for 3B Medical. Until January of 2017, 3B Medical was embroiled in a patent lawsuit with a competing manufacturer of sleep therapy devices, ResMed. The lawsuit spanned 16 actions across three continents, says Alex Lucio, executive vice president at 3B Medical.
Lucio and the 3B Medical team developed the iCodeConnect, a cloud-based device that makes managing and treating sleep disorder patients easier and more efficient.
The customer base for sleep therapy is growing, thanks to greater exposure in the media and those who use mobile device technology for health management, market specialists say. Public awareness of obstructive sleep apnea has increased dramatically due to a proliferation of news reports, advertisements and even discussion of the condition on scripted TV shows.
Settlement ends all existing claims between ResMed and BMC/3B Medical BMC and 3B will pay royalties to ResMed ResMed makes one-time payment to 3B to resolve Florida litigation SAN DIEGO – January 20, 2017 – ResMed (NYSE:RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties.
SAN DIEGO, Calif. and WINTER HAVEN, Fla. (January 24, 2017)-ResMed, BMC and 3B Medical, today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for royalty payments to ResMed, and ResMed will make a one-time settlement payment to 3B to close the Florida litigation between the two parties.
ResMed (NYSE:RMD) and China's BMC Medical agreed to bury the hatchet, saying last week that their agreement puts to bed all of the long-simmering litigation between the sleep apnea device makers. The patent infringement disputes date back at least to June 2013, when ResMed filed a lawsuit against BMC and its U.S.